BioCentury
ARTICLE | Clinical News

Integra Life Sciences Corp. regulatory update

April 15, 2013 7:00 AM UTC

IART said that The Burnham Institute (La Jolla, Calif.) received U.S. Patent No. 5,648,330 covering the use of RGD (arginine-glycine-aspartic acid)-containing peptides to treat thrombosis. The patent ...